Literature DB >> 17423395

Effectiveness of oxibendazole against benzimidazole-resistant strongyles in horses.

J O Slocombe, J F Cote, I McMillan.   

Abstract

Twenty-eight horses with a residual burden of strongyle eggs in the faces after treatment with mebendazole (MBZ) paste were treated with a suspension of either MBZ or oxibendazole (OBZ). Fecal samples were collected before and 14 days after these treatments. The number of strongyle eggs/g (epg) of feces for each horse was estimated using the Cornell-McMaster dilution and the Cornell-Wisconsin double centrifugation procedures. The epg for each horse was transformed using log (x + 1) and in an analysis of variance of the reduction in egg count for each horse on the logarithmic scale, there was a highly significant difference between the treatments. The mean epg was increased in the MBZ-treated horses and reduced in the OBZ-treated horses, but the reduction was only by 82% with an upper confidence limit of 89%. Subsequently, the horses were retreated with MBZ and OBZ suspensions without significant reduction in the mean epg for OBZ-treated horses.

Entities:  

Year:  1989        PMID: 17423395      PMCID: PMC1681156     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  16 in total

1.  Critical and clinical test evaluations of mebendazole against internal parasites of the horse.

Authors:  J H Drudge; E T Lyons; S C Tolliver
Journal:  Am J Vet Res       Date:  1974-11       Impact factor: 1.156

2.  Horse strongyles' tolerance to anthelmintics.

Authors:  M C Round; D J Simpson; C S Haselden; R E Baskerville
Journal:  Vet Rec       Date:  1974-11-30       Impact factor: 2.695

Review 3.  Anthelmintics and drug resistance.

Authors:  R B Wescott
Journal:  Vet Clin North Am Equine Pract       Date:  1986-08       Impact factor: 1.792

4.  Evaluation of the Cornell-Wisconsin centrifugal flotation technique for recovering trichostrongylid eggs from bovine feces.

Authors:  T G Egwang; J O Slocombe
Journal:  Can J Comp Med       Date:  1982-04

5.  Anthelmintic efficacy of oxibendazole in ponies: comparison of methods.

Authors:  V J Theodorides; T Nawalinski; N Chimes; C Weideman; S M Free
Journal:  Am J Vet Res       Date:  1982-05       Impact factor: 1.156

6.  Clinical trials with fenbendazole and oxibendazole for Strongyloides westeri infection in foals.

Authors:  J H Drudge; E T Lyons; S C Tolliver; J E Kubis
Journal:  Am J Vet Res       Date:  1981-03       Impact factor: 1.156

7.  Clinical trials of oxibendazole for control of equine internal parasites including benzimidazole-resistant small strongyles.

Authors:  J H Drudge; E T Lyons; S C Tolliver; J E Kubis
Journal:  Mod Vet Pract       Date:  1981-09

8.  Resistance to benzimidazole anthelmintics in equine strongyles. 2. Evidence of side-resistance, and susceptibility of benzimidazole-resistant strongyles to non-benzimidazole compounds.

Authors:  J H Webster; J D Baird; M Gunawan; I C Martin; J D Kelly
Journal:  Aust Vet J       Date:  1981-04       Impact factor: 1.281

9.  Use of oxibendazole for control of cambendazole-resistant small strongyles in a band of ponies: a six-year study.

Authors:  J H Drudge; E T Lyons; S C Tolliver; T W Swerczek
Journal:  Am J Vet Res       Date:  1985-12       Impact factor: 1.156

10.  Critical tests and clinical trials on oxibendazole in horses with special reference to removal of Parascaris equorum.

Authors:  J H Drudge; E T Lyons; S C Tolliver; J E Kubis
Journal:  Am J Vet Res       Date:  1979-06       Impact factor: 1.156

View more
  2 in total

1.  Comparative long-term efficacy of ivermectin and moxidectin over winter in Canadian horses treated at removal from pastures for winter housing.

Authors:  Johanne Elsener; Alain Villeneuve
Journal:  Can Vet J       Date:  2009-05       Impact factor: 1.008

2.  The persistence of benzimidazole-resistant cyathostomes on horse farms in Ontario over 10 years and the effectiveness of ivermectin and moxidectin against these resistant strains.

Authors:  J Owen D Slocombe; John F Coté; Rolph V G de Gannes
Journal:  Can Vet J       Date:  2008-01       Impact factor: 1.008

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.